IP Library Granted Patent US 8,568,712
Granted Patent B2
US 8,568,712 · App. 13/749,512 · Granted Oct 29, 2013

Enzyme and prebiotic combinations for enhancing probiotic efficacy

Inventors: Randolph S. Porubcan (Victoria, MN); Sonja Lea Yonak (Prior Lake, MN)
Assignee: Master Supplements, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,568,712
App. No.
13/749,512
Granted
Oct 29, 2013
Kind
B2
Abstract

This disclosure relates to enhancing growth and/or activity of lactobacilli using a prebiotic formulation which includes iso-malto oligosaccharides and α-galactosidase; and to enhancing growth and/or activity of bifidobacteria using a prebiotic formulation which includes iso-malto oligosaccharides and β-glucanase. Other combinations of fibers and enzymes are described below which also stimulate growth and activity of lactobacilli or bifidobacteria . These combinations of enzymes and prebiotics can be taken separately or added to foods, including desserts.

Claims (6)

1. A formulation for enhancing lactobacillus growth or activity in vivo consisting of α-galactosidase and isomalto-oligosaccharide.

2. The formulation of claim 1 wherein the lactobacillus species is Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus plantarum or Lactobacillus rhamnosus.

3. A formulation for enhancing bifidobacterium growth or activity in vivo consisting of β-glucanase and isomalto-oligosaccharide.

4. The formulation of claim 3 wherein the bifidobacterium species is Bifidobacterium lactis (strain BL-04 or Bi-07) or Bifidobacterium breve.

5. A formulation for enhancing lactobacillus and bifidobacterium growth or activity in vivo consisting of α-galactosidase, β-glucanase and isomalto-oligosaccharide.

6. The formulation of claim 5 wherein lactobacillus species is Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus paracasei, Lactobacillus plantarum or Lactobacillus rhamnosus and the bifidobacterium species is Bifidobacterium lactis (strain BL-04 or Bi-07) or Bifidobacterium breve.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: PORUBCAN, RANDOLPH S.
To: MASTER SUPPLEMENTS, INC.
Reel/Frame 030282/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2013
From: YONAK, SONJA L.
To: MASTER SUPPLEMENTS, INC.
Reel/Frame 030282/0708 →
Continuity (7)
Continuation In Part 13267042 · Oct 6, 2011
Continuation 12022380 · Jan 30, 2008
Continuation 13749512
Continuation In Part 13118550 · May 30, 2011
Provisional Application 60887628 · Feb 1, 2007
Provisional Application 61363172 · Jul 9, 2010
Related Publication 20130115203A1 · May 9, 2013